Y-Intercept (HK)’s GoodRx Holdings GDRX Stock Holding History

Y-Intercept (HK)’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,427	Closed	-$131K	–	1562
2024 Q1	$131K	Sell	18,427 -11,767	-39%	-$77.8K	0.01%	1238
2023 Q4	$202K	Buy	+30,194	New	+$170K	0.02%	1003
2023 Q3	–	Sell	-12,794	Closed	-$70.6K	–	1229
2023 Q2	$70.6K	Buy	+12,794	New	+$68.9K	0.01%	1166
2023 Q1	–	Sell	-37,632	Closed	-$175K	–	1302
2022 Q4	$175K	Buy	+37,632	New	+$185K	0.03%	847
2022 Q3	–	Sell	-62,011	Closed	-$367K	–	1080
2022 Q2	$367K	Buy	+62,011	New	+$690K	0.05%	520
2022 Q1	–	Sell	-13,479	Closed	-$440K	–	799
2021 Q4	$440K	Buy	+13,479	New	+$542K	0.1%	281
2021 Q2	–	Sell	-6,937	Closed	-$263K	–	723
2021 Q1	$263K	Buy	+6,937	New	+$312K	0.07%	462

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Y-Intercept (HK)'s GDRX Position: Q2 2024 in Review

Y-Intercept (HK) sold out of GoodRx Holdings (GDRX) in Q2 2024, closing a stake of 18,427 shares — an estimated $131K sold.

Y-Intercept (HK) first reported a position in GDRX in Q1 2021 and held it in 7 quarters. The position peaked at $440K in Q4 2021. 165 funds tracked by Wall St. Rank hold GDRX as of Q2 2024.

Y-Intercept (HK) reported no remaining GoodRx Holdings position as of Q2 2024 after selling out during the quarter.
Y-Intercept (HK) sold 18,427 GoodRx Holdings shares in Q2 2024, an estimated $131K.
Y-Intercept (HK) first reported a position in GoodRx Holdings in Q1 2021 and held it in 7 quarters.
Y-Intercept (HK)'s GoodRx Holdings position peaked at $440K in Q4 2021.
165 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.